IXICO has provided a trading update confirming its FY23E revenue expectation of £7m and indicating it expects to achieve double-digit revenue growth in FY24E. We believe the impact of the historical trial cessations will wash out in FY23E, marking the nadir of this event, with a return to revenue growth for FY24E. Based on the diversified order book, we believe this revenue growth should be sustainable and resilient, forming the basis for a return to profitability. With this report we introduce ....
